معرفی
James Barrett, PhD, is an Adjunct Professor in the Department of Neural Sciences at the Lewis Katz School of Medicine, Temple University, and is affiliated with the Center for Substance Abuse Research. He has a distinguished career in pharmacology, behavioral neuroscience, and translational research, with extensive leadership experience in academia and the pharmaceutical industry, including roles as Chair of Pharmacology and Physiology and Founding Director of key research and educational programs at Drexel University.
Education and Training:
- Postdoctoral Fellowship, Neuropsychopharmacology and Behavioral Pharmacology, Worcester Foundation for Experimental Biology, Shrewsbury, MA
- PhD, Biopsychology/Neurobiology, Pennsylvania State University, State College, PA
Research Interests: Dr. Barrett's research spans the pharmacology of pain and substance abuse disorders, with a focus on drug discovery and development. His work integrates behavioral models with molecular and translational approaches to understand CNS disorders. His expertise includes behavioral pharmacology, ion channel modulation, neuroinflammation, and epigenetic regulation of pain and psychiatric conditions.
Publication Trends: His recent publications emphasize the role of ion channels (e.g., Orai1, P2X7), microRNA signatures, and epigenetic mechanisms in pain and neurobehavioral disorders. There is a strong translational focus, with studies bridging preclinical models and clinical applications in pain, addiction, and mental health.
Scientific Awards and Honors:
- Solvay-Duphar Award for Preclinical Research on Affective Disorders (1991)
- George B. Kolle Award (2010)
- P.B. Dews Lifetime Achievement Award (2012)
- Torald Sollmann Award (2015)
- Distinguished Lecturer, University of Texas Medical Branch (2015)
Leadership and Mentorship: Dr. Barrett has held major leadership roles in academic pharmacology, including Past President of the Behavioral Pharmacology Society, ASPET, and the Association of Medical School Pharmacology Chairs. He has contributed significantly to graduate education and curriculum development in pharmacology, aiming to prepare students for careers in biotechnology and pharmaceutical industries. While specific students are not listed, his extensive collaborative work suggests a strong advisory and mentorship role.
Laboratories and Research Teams: His research has been conducted in collaboration with multidisciplinary teams, particularly through the Center for Substance Abuse Research. His work often involves partnerships across institutions, focusing on CNS drug development and behavioral assessment models.
